返回 Agendas
Outing Innovation: How Partnerships Help (and Hinder) the Movement Toward Novel Approaches to Clinical Development
Session Chair(s)
John A. Rafa, MBA
Director, Research and Market Intelligence
Acurian, United States
Results from industry research and a sharing of executive panel perspectives on clinical trial innovation will serve as a catalyst for audience discussion. This forum will discuss the impact that partnering arrangements will have on innovation.
Learning Objective : Describe what novel approaches to clinical trial execution are being employed; Explain how partnerships between sponsors and contract research organizations are supporting (or detracting from) innovation in trial design and execution; Discuss how innovation initiatives are structured within the industry including the degree to which desired benefits have been realized.
Speaker(s)
Panelist
Craig Lipset, MPH
Decentralized Trials & Research Alliance | Buffalo Initiative, United States
Co-Chair
Panelist
Thomas Grundstrom, MA
Marken, United States
Senior Vice President, IT Strategy, Technology, and Business Analytics
Panelist
Nik Morton, MS
Catalyst Clinical Research, United States
Chief Operating Officer
Panelist
Katherine J Vandebelt
Eli Lilly and Company, United States
Senior Director, Clinical Innovation
注册方法
Registration override should work.